Goncagul Akdag
Kartal, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.
Journal: Immunotherapy
Published: September 02, 2026
Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: March 04, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 06, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 06, 2026
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study.
Journal: Journal of chemotherapy (Florence, Italy)
Published: December 19, 2025
Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.
Journal: Journal of personalized medicine
Published: December 09, 2025
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes.
Journal: Journal of clinical medicine
Published: December 04, 2025
Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: December 02, 2025
Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study.
Journal: Medicina (Kaunas, Lithuania)
Published: November 21, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Journal: Future oncology (London, England)
Published: October 17, 2025
The impact of sarcopenia on adverse effects and survival in patients with metastatic hormone receptor-positive breast cancer treated with CDK4/6 inhibitors.
Journal: Medicine
Published: July 15, 2025
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.
Journal: Journal of clinical medicine
Published: May 14, 2025
Last Updated: 09/26/2026